UnitedHealth Group Inc (UNH) Position Lifted by Alpha Cubed Investments LLC

Alpha Cubed Investments LLC lifted its stake in UnitedHealth Group Inc (NYSE:UNH) by 16.1% during the first quarter, Holdings Channel reports. The institutional investor owned 22,183 shares of the healthcare conglomerate’s stock after acquiring an additional 3,075 shares during the period. Alpha Cubed Investments LLC’s holdings in UnitedHealth Group were worth $4,747,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Exane Derivatives boosted its stake in UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after purchasing an additional 460 shares during the period. Aevitas Wealth Management Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth $102,000. Pathstone Family Office LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $129,000. Trustcore Financial Services LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $133,000. Finally, Wealthcare Advisory Partners LLC boosted its stake in UnitedHealth Group by 461.9% during the 3rd quarter. Wealthcare Advisory Partners LLC now owns 826 shares of the healthcare conglomerate’s stock worth $162,000 after purchasing an additional 679 shares during the period. 85.10% of the stock is currently owned by hedge funds and other institutional investors.

Shares of UnitedHealth Group opened at $241.51 on Friday, according to MarketBeat.com. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.56. UnitedHealth Group Inc has a 52 week low of $174.92 and a 52 week high of $250.79. The stock has a market capitalization of $232.72 billion, a P/E ratio of 23.98, a P/E/G ratio of 1.40 and a beta of 0.75.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 17th. The healthcare conglomerate reported $3.04 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.91 by $0.13. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. The firm had revenue of $55.19 billion during the quarter, compared to analysts’ expectations of $54.90 billion. During the same quarter last year, the business earned $2.37 earnings per share. The business’s revenue for the quarter was up 13.3% compared to the same quarter last year. research analysts anticipate that UnitedHealth Group Inc will post 12.61 EPS for the current fiscal year.

In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 202 shares of the firm’s stock in a transaction dated Thursday, April 19th. The shares were sold at an average price of $237.42, for a total transaction of $47,958.84. Following the completion of the transaction, the director now directly owns 28,948 shares in the company, valued at approximately $6,872,834.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Larry C. Renfro sold 22,184 shares of the firm’s stock in a transaction dated Thursday, March 15th. The shares were sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the transaction, the insider now owns 173,229 shares of the company’s stock, valued at $39,659,047.26. The disclosure for this sale can be found here. Insiders sold 76,619 shares of company stock valued at $17,892,385 in the last quarter. Company insiders own 0.87% of the company’s stock.

A number of brokerages recently weighed in on UNH. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. Piper Jaffray Companies restated a “buy” rating and issued a $270.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 18th. Credit Suisse Group raised their target price on shares of UnitedHealth Group from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 18th. Finally, Oppenheimer raised their target price on shares of UnitedHealth Group from $260.00 to $276.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 18th. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $254.66.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply